基于肿瘤原发灶及瘤周区域PET/CT影像组学预测肺腺癌淋巴结转移的价值研究

A study on the value of PET/CT radiomics based on the primary tumor and peritumoral region for predicting lymph node metastasis in lung adenocarcinoma

  • 摘要:
    目的 探讨基于18F-氟代脱氧葡萄糖(18F-FDG PET/CT)的肿瘤原发灶及瘤周区域影像组学在预测肺腺癌淋巴结转移中的价值,并比较不同机器学习算法的预测效能。
    方法 收集本院224例肺腺癌患者作为内部数据集,另从癌症影像档案(TCIA)公共数据库筛选85例作为独立外部验证集。提取肿瘤原发灶及瘤周5 mm区域的PET/CT组学特征。经组内相关系数(ICC)、Spearman秩相关分析和最小绝对收缩和选择算子(LASSO)回归筛选出9个核心特征(肿瘤区6个,瘤周区3个)。基于肿瘤区、瘤周区及肿瘤-瘤周联合特征集分别构建逻辑回归(LR)、支持向量机(SVM)、随机森林(RF)、K-近邻(KNN)及极限梯度提升(XGBoost)共5种模型。采用受试者操作特征(ROC)曲线与决策曲线分析(DCA),对比评估各模型的预测效能与临床获益。
    结果 内部测试集中,联合特征集的XGBoost模型曲线下面积(AUC)值最高,为0.899(95%CI为0.828~0.970)。经Bonferroni校正,XGBoost仅与KNN模型的差异有统计学意义(P = 0.009),与SVM、LR及RF模型的差异均无统计学意义(均P > 0.013)。外部验证队列中,联合特征集的XGBoost模型AUC为0.887(95%CI为0.825~0.965),经Bonferroni校正后仍优于肿瘤区模型(AUC = 0.810)及瘤周区模型(AUC = 0.779),差异均有统计学意义(均P < 0.017)。DCA显示,联合特征集的XGBoost模型在不同队列下均能带来更高的临床净获益。
    结论 整合PET/CT肿瘤原发灶及瘤周区域影像组学特征,可提高淋巴结转移预测效能。基于联合特征集的XGBoost模型具有良好的准确性和泛化能力,可为临床术前评估提供决策依据。

     

    Abstract:
    Objective To investigate the value of PET/CT radiomics based on the primary tumor and peritumoral region on 18F-fluorodeoxyglucose (18F-FDG) PET/CT in predicting lymph node metastasis in lung adenocarcinoma, and to compare the predictive performance of different machine learning algorithms.
    Methods A total of 224 patients with lung adenocarcinoma from our hospital were included as the internal dataset, and an additional 85 patients were selected from the public Cancer Imaging Archive (TCIA) database as an independent external validation set. PET/CT radiomic features were extracted from the primary tumor and the 5-mm peritumoral region. Nine core features, including six from the tumor region and three from the peritumoral region, were selected using the intraclass correlation coefficient (ICC), Spearman rank correlation analysis, and least absolute shrinkage and selection operator (LASSO) regression. For each of the tumor-region, peritumoral-region, and combined tumor-peritumoral feature sets, five models were constructed using logistic regression (LR), support vector machine (SVM), random forest (RF), K-nearest neighbors (KNN), and extreme gradient boosting (XGBoost). Receiver operating characteristic (ROC) curves and decision curve analysis (DCA) were used to compare and evaluate the predictive performance and clinical benefit of the models.
    Results In the internal test set, the XGBoost model based on the combined feature set achieved the highest area under the curve (AUC), at 0.899 (95% CI: 0.828-0.970). After Bonferroni correction, the difference was statistically significant only between the XGBoost and KNN models (P = 0.009), while no statistically significant differences were observed between the XGBoost model and the SVM, LR, or RF models (all P > 0.013). In the external validation cohort, the XGBoost model based on the combined feature set achieved an AUC of 0.887 (95% CI: 0.825-0.965) and remained superior to the tumor-region model (AUC = 0.810) and the peritumoral-region model (AUC = 0.779) after Bonferroni correction, with both differences being statistically significant (both P < 0.017). DCA showed that the XGBoost model based on the combined feature set yielded a higher clinical net benefit across all cohorts.
    Conclusions Integrating PET/CT radiomic features from the primary tumor and peritumoral region can improve the predictive performance for lymph node metastasis. The XGBoost model based on the combined feature set demonstrates good accuracy and generalizability and can provide decision support for clinical preoperative assessment.

     

/

返回文章
返回